|
|
|
Zonegran
(zonisamide, Elan Pharmaceuticals) An adjunctive antiseizure drug for people 16 and over with partial seizures. * Recommended Dosage: Starting at ...
From OB/GYN News,
5/15/00
by Elizabeth Mechcatie
| |
|
|
Zonegran
(zonisamide, Elan Pharmaceuticals) An adjunctive antiseizure drug for people 16 and over with partial seizures. * Recommended Dosage: Starting at ...
From Family Pratice News,
5/15/00
by Elizabeth Mechcatie
| |
|
|
A Comprehensive Medicine approach to migraines
For this pain issue, I have excerpted part of the section on the treatment of migraines from my new book Pain Free 1-2-3!-A Proven Program to Get You ...
From Townsend Letter for Doctors and Patients,
1/1/05
by Jacob Teitelbaum
| |
|
|
Recommendations for prescribing new antiepileptic drugs
Several new antiepileptic drugs (AEDs) are effective in treating selected patients with partial or mixed seizure disorders, but evidence for their efficacy ...
From American Family Physician,
9/15/04
by Carrie A. Morantz
| |
|
|
Elan Completes Sale of Zonegran to Eisai
Business Editors/Health/Medical Writers DUBLIN, Ireland--(BUSINESS WIRE)--April 27, 2004 Elan Corporation, plc today announced the completion of ...
From Business Wire,
4/27/04
| |
|
|
Eisai
Supplier News--Eisai last month closed the deal on acquiring the epilepsy treatment Zonegran (zonisamide) from Elan Pharma. As part of the agreement, ...
From Drug Store News,
5/17/04
by James Frederick
| |
|
|
Elan Announces Strategic Transaction; Eisai to Purchase Elan's Interests in Zonegran in North America and Europe
Business Editors/Health/Medical Writers DUBLIN, Ireland--(BUSINESS WIRE)--March 30, 2004 Elan Corporation, plc today announced an agreement with ...
From Business Wire,
3/30/04
| |
|
|
FDA Approves New Dosage Strengths of Elan's Zonegran; Providing Flexible Dosing Options For Improved Management of Patients
Business Editors DUBLIN--(BUSINESS WIRE)--Aug. 29, 2003 Elan Corporation, plc (NYSE: ELN) ("Elan") today announced that it has received approval ...
From Business Wire,
8/29/03
| |
|